Recently, the clove garden and the United States critical illness medical service organization MORE Health love medical communication to reach a cooperation, the two sides jointly established the Sino-US critical and critical illness authority exchange platform, has now officially launched.
The platform is a medical exchange between China and the United States, which is dedicated to the academic exchange of critical and difficult diseases between China and the United States. It shares the case of China-US remote consultation of critically ill and the latest medical research in the world.
Going abroad to see a disease, the trend is high, and the patient is stopped.
Statistics from the Ministry of Commerce show that in 2017, Chinese tourists spent a total of US$51 billion on travel to the United States (including going abroad for medical treatment). Among the people who go abroad to see a doctor, the "million-dollar bottoming" is the norm. According to statistics from a travel platform, the total number of Chinese people going abroad for medical treatment in 2017 was about 500,000.
There are many reasons for Chinese people to choose to go abroad for medical treatment. There is no shortage of domestic medical resources and poor medical experience. It is a reason for many people to choose to go abroad for medical treatment. It is understood that at present, 90% of the original research drugs in the world come from the United States, and these drugs often enter the Chinese market after a few years of listing.
However, the large amount of time and economic costs of going abroad for medical treatment will impose a heavy burden on the family. At the same time, once returned to the country, it is difficult to ensure continuity of treatment for patients abroad. This kind of problem is particularly prominent in cancer treatment. Many new drugs approved by the US FDA have not been approved for marketing in China, which makes it difficult for patients to continue taking drugs after returning home.
Overseas medical treatment for critically ill patients
According to statistics from a number of institutions, critically ill patients, especially cancer patients, are the main source of medical care for overseas Chinese. There are two reasons for this. First, domestic cancer patients are on the rise, domestic medical resources are difficult to meet, and on the other hand, there is a certain gap between domestic cancer medical care and foreign countries.
According to the National Cancer Registry Data Center, there are about 3.12 million new cases of cancer every year in China, with an average of 8,550 people per day. Six people per minute are diagnosed with cancer. In the next decade, China's cancer morbidity and mortality will continue to climb. It is estimated that by 2020, China's annual cancer deaths will reach 3 million, and the total number of diseases will reach 6.6 million. The number of tumors rising in a straight line, China's medical resources will be difficult to meet.
In addition, China's medical level is leading the international market in some fields, but there is still a certain gap between the treatment level and treatment concept of complex diseases and the international advanced level. Take the statistics of the Anderson Cancer Center in the United States as an example. The 5-year survival rate of cancer in Chinese patients is about 36%, compared with 66% in American patients.
Open high-end consultation to help patients share medical resources
"Based on the above reasons, it is extremely urgent to get high-end consultations so that people do not have to pay for the huge expenses of going abroad for medical treatment." MORE Health's Chief Strategy Officer (CSO) James Zhang said.
Founded in 2011 and headquartered in Silicon Valley, MORE Health is a medical services organization focused on critical and ill diseases. MORE Health's medical communication team is committed to integrating high-end medical resources between China and the United States to provide medical treatment and medical services to Chinese and American users. Unlike the intermediary model adopted by some cross-border medical startups, MORE Health loves to deliver a network data platform for remote high-end medical care in China and the United States. The agency has developed a cloud-based international expert consultation platform with independent patents, and has been certified by the US FDA to comply with the US Health Insurance Portability and Accountability Act (HIPPA).
At present, MORE Health has signed more than 700 top 1% of top doctors in the United States. The specialist doctors cover the fields of cancer, cardiovascular, neurological, pediatric, obstetrics and gynecology and rare diseases. Since entering the Chinese market in 2016, it has signed contracts with more than a dozen top three hospitals in China, and has established cooperative relationships with doctors in hundreds of hospitals to provide first-class medical services to Chinese and American users.
"We use the way that American experts and patients with Chinese doctors consult and discuss treatment programs, so that Chinese critically ill patients can enjoy the top medical resources in the United States without going abroad, and achieve medical treatment in the country and save medical expenses." More Health Love Chief Medical Officer and Co-Founder, Dr. Dr. Robert Warren said.
It is worth mentioning that, to date, MORE Health has provided Chinese and American teleconsultation services to thousands of domestic patients, and more than 75% of cancer patients have undergone major adjustments to the treatment plan after the Sino-US consultation, 95% The above patients with cranial nerve diseases changed their diagnosis and treatment after the Chinese and American consultations. After the consultation, 95% of the patients continue to be treated in the country without going to the United States.
A patient who had undergone a Sino-US consultation said, "Through the Sino-US consultation, MORE Health loved the doctor not only matched me to the top doctors in the United States, but also the American doctors discussed with my Chinese doctor according to my condition. And give a more appropriate diagnosis and treatment, so that you do not have to go abroad to achieve the effect of going abroad for medical treatment, and save a lot of time and money, while also ensuring my follow-up treatment in the country."
Medical without borders join forces to build a telemedicine international consultation platform
The benefits of cross-border healthcare in integrating quality healthcare resources are obvious, but not easy in practice.
For users, the process is often cumbersome and costly; for doctors, in addition to language barriers, the medical norms and habits of the two places are not the same; for the platform, in addition to the need to integrate doctors and medical resources from both places, There is also a need to provide accurate translation services and convenient communication tools to increase the appeal of the platform to quality doctors in both places. This has become the embarrassment of many cross-border medical enterprises in China.
"This cooperation with MORE Health will promote the exchange of quality medical resources between China and the United States, and benefit patients together." Shuai Yuhuan, vice president of Lilac Garden, said that since its establishment in 2000, Lilac Garden has been focusing on medicine and life. Internet practice in the field of science, and is committed to connecting stakeholders in the medical and health fields such as doctors and patients, so that the public can enjoy reliable medical services.
"Inheriting the concept of medical without borders, MORE Health loves to pass on the choice of clove garden. We hope to serve more patients." Dr. Robert Warren said that despite the current escalation of Sino-US trade wars, MORE Health has always insisted on advancing the process of medical without borders, helping the Chinese and American medical circles to exchange visits, and promoting the improvement of domestic critical medical care, actively for China and The world's patients provide professional medical services to benefit more patients.
This clove garden and MORE Health love medical transfer jointly created the Aizhong Sino-American Consultation College, which will create a Sino-US expert lecture hall, consultation case tour, international frontier therapy and other sections, which will pay more attention to the latest treatments in the international difficult and critical illness areas. A team of progressive doctors and patients providing an authoritative platform for information and communication.
Shenzhen Guangyang Zhongkang Technology Co., Ltd. , https://www.syztreatment.com